A carregar...
Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.
New fluoroquinolones have generally been well tolerated. In a double-blind evaluation of oral fleroxacin, using 400, 600, or 800 mg once daily for 7 days in an ambulatory setting for treatment of uncomplicated genital infections, we encountered unexpectedly high rates of adverse reactions. The objec...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1989
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC172754/ https://ncbi.nlm.nih.gov/pubmed/2511802 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|